News
Article
Pharmaceutical Technology
Pharmaceutical Technology-05-15-2015Volume2015 eBook Issue 2
Controlled Nucleation for a Monoclonal Antibody Formulation—A Case Study
Author(s):
This study evaluates the impact of controlled nucleation on the ability to optimize a lyophilization cycle for a monoclonal antibody formulation.
This study evaluates the impact of controlled nucleation on the ability to optimize a lyophilization cycle for a monoclonal antibody formulation.
Download
Pharmaceutical Technology’s 2015 Bioprocessing and Sterile Manufacturing eBook
Articles in this issue
Sterilization Effects on Elastomers in Sterile Parenteral Drug Products
Controlled Nucleation for a Monoclonal Antibody Formulation—A Case Study
Validating and Implementing a Rapid Sterility Testing Method
Disposable Technology versus Traditional Stainless Steel--When Time Means Money
Cleanroom and Facility Planning: Getting Beyond Cost Per Square Foot
Aging Facilities: Aseptic Manufacturing Faces the Future
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Videos
Related Content
